Loading…

Medical Research Finder

Gut microbiota / Evidence-based microbiome knowledge (incl. AI chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Multiple sclerosis (MS)

Welcome to meRfi-GM!

Please register to continue your trial period!

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) characterized by neuroinﬂammation and neurodegeneration (1). It is neurological disorder characterized by axonal damage and demyelination of oligodendrocytes in the CNS associated with progressive neurological disability, and can be caused by numerous environmental and genetic factors (2, 3).

Relapsing remitting Mult…

A population-based study of multiple sclerosis in twins: Update
Sadovnick et al. 2004 Ann. Neurol. 33: 281–285
Melatonin contributes to the seasonality of multiple sclerosis relapses
Farez et al. 2015 Cell 162: 1338-1352
Microglia in Central Nervous System Inﬂammation and Multiple Sclerosis Pathology
Voet et al. 2019 Trends Mol. Med. 25: 112–123
Review
Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes
Ja¨ger et al. 2009 J. Immunol. 183: 7169-7177
Th22 cells are expanded in multiple sclerosis and are resistant to IFN- β
Rolla et al. 2014 J. Leukoc. Biol. 96: 1155–1164
The changing demographic pattern of multiple sclerosis epidemiology
Koch-Henriksen & Sorensen 2010 Lancet Neurol. 9(5): 520–32
Review
The risk of smoking on multiple sclerosis: A meta-analysis based on 20,626 cases from case-control and cohort studies
Zhang et al. 2016 PeerJ 4: e1797

2/26/2026